Health CarePharmaceuticals & Biotechnology
  • Price (JPY)4,477.00
  • Today's Change9.00 / 0.20%
  • Shares traded511.70k
  • 1 Year change-9.02%
  • Beta0.7323
Data delayed at least 20 minutes, as of Jan 21 2021 04:51 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Otsuka Holdings Co., Ltd. is a Japan-based company mainly engaged in the medical and nutraceuticals related business and other businesses. The Company operates through four business segments. The Medical-related segment is engaged in the sale of ethical drugs, and the research development and export of therapeutic drugs. The Nutraceuticals-related segment is engaged in the manufacture, purchase and sale of nutraceuticals-related products, such as functional food and dietary supplements. The Consumer-related segment is engaged in the manufacture and sale of consumer products and mineral water. The Others segment is engaged in the manufacture and sale of chemical products, the manufacture, sale and import of measuring equipment, and the manufacture of synthetic resin molding products.

  • Revenue in JPY (TTM)1.43tn
  • Net income in JPY143.40bn
  • Incorporated2008
  • Employees32.99k
  • Location
    Otsuka Holdings Co Ltd2-9, Kandatsukasa-machiCHIYODA-KU 101-0048JapanJPN
  • Phone+81 367171410
  • Fax+81 367171409
  • Websitehttps://www.otsuka.com/jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
TAISHO PHARMACEUTICAL HOLDINGS Co Ltd302.22bn16.85bn600.23bn9.35k33.440.786814.751.99210.79210.793,782.358,959.970.35452.474.8532,309,
Kobayashi Pharmaceutical Co Ltd155.31bn19.15bn1.00tn3.44k49.795.3042.076.45245.03245.031,987.062,301.240.69053.313.2845,214,560.008.51--10.60--57.87--12.33--3.53--0.0038--0.3421--6.19------
Shionogi & Co Ltd318.19bn117.19bn1.77tn5.22k14.912.1113.595.57381.41381.411,033.152,696.160.37231.295.1660,932,210.0013.7114.0114.9915.8383.6880.0136.8230.577.26--0.013325.13-9.404.00-10.9322.63-2.5314.65
Otsuka Holdings Co Ltd1.43tn143.40bn2.49tn32.99k17.111.3210.981.73260.52260.522,645.113,365.660.55222.644.0543,478,420.005.654.236.835.2068.7566.8110.247.992.01--0.112952.458.07--54.14------
Astellas Pharma Inc1.27tn139.72bn3.09tn15.88k22.182.3214.662.4474.8674.86679.39715.830.60041.693.7979,698,670.006.6310.568.9714.0579.6676.9511.0415.091.08--0.235336.12-0.42140.8448-12.087.54-0.82115.92
Takeda Pharmaceutical Co Ltd3.22tn56.05bn5.67tn47.50k100.951.219.811.7635.6635.662,055.362,982.300.25471.284.2067,834,590.000.44311.630.51082.0768.4868.861.745.281.081.570.5126164.4456.9313.11-67.28--14.900.00
Chugai Pharmaceutical Co Ltd753.85bn202.59bn9.67tn7.39k46.7910.24--12.83123.15123.15458.27562.880.69761.523.57101,954,700.0018.7510.3422.5312.2564.8154.4526.8715.803.05529.710.0049.7618.358.2770.3625.3226.1323.87
Data as of Jan 21 2021. Currency figures normalised to Otsuka Holdings Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

16.38%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 30 Aug 201924.76m4.44%
The Vanguard Group, Inc.as of 31 Dec 202011.46m2.05%
Daiwa Asset Management Co. Ltd.as of 30 Dec 202011.42m2.05%
Nikko Asset Management Co., Ltd.as of 30 Dec 202011.28m2.02%
T. Rowe Price International Ltd.as of 30 Sep 20208.03m1.44%
Norges Bank Investment Managementas of 31 Dec 20196.38m1.14%
BlackRock Fund Advisorsas of 07 Jan 20216.02m1.08%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.as of 12 Oct 20205.55m1.00%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Nov 20203.56m0.64%
Geode Capital Management LLCas of 14 Jan 20212.91m0.52%
More ▼
Data from 31 Dec 2019 - 30 Nov 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.